Tags : Merck KGaA

Merck KGaA Takes an Early Option in its Existing Immuno-Oncology

Shots: F-star to receive option exercise payment and will be eligible to get milestones and royalties on net sales of therapies resulting from the collaboration. Merck KGaA exercises its option to license a preclinical program in its existing agreement with F-star Merck KGaA will be responsible for the development and commercialization of the preclinical program […]Read More

PharmaShots Weekly Snapshot (Jun 22- 26, 2020)

 1.  EMA’s CHMP Recommends the Approval of Two Biosimilar Referencing Lilly’s Forsteo (teriparatide) for the Treatment of Osteoporosis Published: Jun 26, 2020 | Tags: EMA, CHMP, Recommend, Approval, Two, Biosimilar, Referencing, Lilly, Forsteo, teriparatide, Osteoporosis 2.  Medtronic Receives the US FDA’s Approval for its Percept PC Neurostimulator with BrainSense Technology Published: Jun 25, 2020 | Tags: Medtronic, […]Read More

Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20

The American Society of Clinical Oncology (ASCO) is a platform for cancer experts to share views on the latest advancements and new approaches in cancer research and was held virtually this year due to the COVID-19 pandemic. The program features over 250 virtual oral abstract presentations and virtual 2,500 poster presentations in 24 disease-based and […]Read More

Top 20 BioPharma Companies based on 2019 Total Revenue

The global biopharma companies are developing novel therapies & devices which is, in turn, enhancing their portfolio and encouraging them in this undergoing competition to stay in the topmost position. The top 20 companies’ chartbusters changed their 2019 ranking, but the history of Johnson and Johnson did not change and it continued being at the […]Read More

PharmaShots Weekly Snapshot (March 23-27, 2020)

1. Mylan Delays its Merger with Upjohn Due to COVID-19 Pandemic Published: Mar 26, 2020 | Tags: Mylan, Delays, Merger, Upjohn, Due, COVID-19 Pandemic 2.  Medopad Provides its Remote Patient Monitoring Platform to Support Global COVID-19 Pandemic2 Published: Mar 26, 2020 | Tags: Medopad, Provides, Remote Patient Monitoring Platform, Support, Global, COVID-19 Pandemic 3.  Quidel’s […]Read More

Insights+: Breakthrough Therapy Designation by the US FDA in 2019

Breakthrough Therapy (BT) Designation is an expedited review program introduced in Section 902 of the Food and Drug Safety and Innovation Act of 2012. The Breakthrough Designation is granted to the drug candidates as monotherapy or in combination with other drugs intended to treat serious or life-threatening diseases and has shown substantial improvement over available […]Read More